BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 6, 2024
Distillery Therapeutics

Decreasing hepatic oxalate levels for MASH

BioCentury | Aug 27, 2021
Distillery Therapeutics

Increasing AGXT expression to treat atherosclerosis

BioCentury | Jan 16, 2019
Distillery Therapeutics

Endocrine/metabolic

BioCentury | Oct 16, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

BioCentury | Apr 30, 2012
Clinical News

AMT-030 regulatory update

Items per page:
1 - 5 of 5
Help Center
Username
Request Training
Submit Data Correction
Ask a Question